Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
Rhea-AI Summary
Enovis (NYSE: ENOV), a medical technology growth company, has announced it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time. The company will issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com.
Investors can access the live webcast via a link on the Enovis website. Those planning to participate on the call should dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A replay of the call will be available on the Enovis website later that day.
Positive
- Enovis is hosting a conference call to discuss Q3 2024 financial results, indicating transparency with investors
- The company is providing multiple ways for investors to access the call, including a live webcast and dial-in options
Negative
- None.
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2024 financial results on Wednesday, November 6th, 2024 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on ir.enovis.com.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
investorrelations@enovis.com
FAQ
When will Enovis (ENOV) report its Q3 2024 earnings?
How can investors participate in Enovis's (ENOV) Q3 2024 earnings call?
Where can I find the presentation for Enovis's (ENOV) Q3 2024 earnings call?
Will there be a replay available for Enovis's (ENOV) Q3 2024 earnings call?
